These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 29680201

  • 1. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y, Palladino G, Xie Y, Ferrari A, Settembre EC.
    Vaccine; 2018 May 17; 36(21):3010-3017. PubMed ID: 29680201
    [Abstract] [Full Text] [Related]

  • 2. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
    Morgenstern K, Xie Y, Palladino G, Barr JR, Settembre EC, Williams TL, Wen Y.
    Vaccine; 2018 Oct 01; 36(41):6144-6151. PubMed ID: 30194004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F, Jing X, Joshi M, Vasudevan A, Soto J, Li X, Choudhary A, Baichoo N, Resnick J, Ye Z, McCormick W, Weir JP.
    Influenza Other Respir Viruses; 2016 Mar 01; 10(2):134-40. PubMed ID: 26616263
    [Abstract] [Full Text] [Related]

  • 8. Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
    Engelhardt OG, Edge C, Dunleavy U, Guilfoyle K, Harvey R, Major D, Newman R, Penn R, Skeldon S, Storey C, Wheeler J, Wood J, Minor P.
    Vaccine; 2018 Jul 05; 36(29):4339-4345. PubMed ID: 29895503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP.
    Vaccine; 2010 Mar 11; 28(12):2442-9. PubMed ID: 20074687
    [Abstract] [Full Text] [Related]

  • 11. Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine.
    Li C, Xu K, Hashem A, Shao M, Liu S, Zou Y, Gao Q, Zhang Y, Yuan L, Xu M, Li X, Wang J.
    Hum Vaccin Immunother; 2015 Mar 11; 11(6):1351-6. PubMed ID: 25970793
    [Abstract] [Full Text] [Related]

  • 12. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    Verma S, Soto J, Vasudevan A, Schmeisser F, Alvarado-Facundo E, Wang W, Weiss CD, Weir JP.
    PLoS One; 2017 Mar 11; 12(4):e0175733. PubMed ID: 28423025
    [Abstract] [Full Text] [Related]

  • 13. Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin.
    Eichelberger SL, Sultana I, Gao J, Getie-Kebtie M, Alterman M, Eichelberger MC.
    Influenza Other Respir Viruses; 2013 Nov 11; 7(6):961-8. PubMed ID: 23496824
    [Abstract] [Full Text] [Related]

  • 14. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 15. Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza.
    Vodeiko GM, Weir JP.
    Influenza Other Respir Viruses; 2012 May 15; 6(3):176-87. PubMed ID: 21902817
    [Abstract] [Full Text] [Related]

  • 16. Stability of neuraminidase in inactivated influenza vaccines.
    Sultana I, Yang K, Getie-Kebtie M, Couzens L, Markoff L, Alterman M, Eichelberger MC.
    Vaccine; 2014 Apr 17; 32(19):2225-30. PubMed ID: 24613525
    [Abstract] [Full Text] [Related]

  • 17. Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies.
    Narayan K, Paduraru C, Blake T, Arunachalam AB.
    Front Immunol; 2023 Apr 17; 14():1128683. PubMed ID: 37457687
    [Abstract] [Full Text] [Related]

  • 18. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
    Kommareddy S, Baudner BC, Bonificio A, Gallorini S, Palladino G, Determan AS, Dohmeier DM, Kroells KD, Sternjohn JR, Singh M, Dormitzer PR, Hansen KJ, O'Hagan DT.
    Vaccine; 2013 Jul 25; 31(34):3435-41. PubMed ID: 23398932
    [Abstract] [Full Text] [Related]

  • 19. A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines.
    Buffin S, Ikhelef N, Prudent J, Dubayle J, Nougarede N, Varenne MP, Moste C, Legastelois I.
    J Virol Methods; 2018 Jan 25; 251():46-53. PubMed ID: 29030070
    [Abstract] [Full Text] [Related]

  • 20. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J, Vandenberg K, Laurie K, Barr IG, Zhang Y, Rockman S.
    Front Immunol; 2023 Jan 25; 14():1147028. PubMed ID: 37033922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.